Long-term non-progressors (LTPNs) in HIV infection target the structural protein Gag more frequently than individuals who progress to disease. However, the targeting of Gag per se does not always distinguish these two groups. Various factors have been put forth as likely explanations for this discrepancy including differences in the breadth and magnitude of observed responses, the HLA type of the host, the nature of the individual epitopes targeted and the ability of the virus to mutate these antigenic regions. The purpose of this thesis was to examine, using PBMCs isolated from HIV-2 infected LTNPs and CTL clones established in vitro, the clonotypic architecture and quality of an immunodominant HIV-2 Gag-specific response directed towards ...
The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effec...
The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effec...
Mapping the precise determinants of T-cell efficacy against viruses in humans is a public health pri...
HIV remains a global pandemic. No vaccine or cure exists. Most infected individuals progress to AIDS...
Background: HIV Controllers are rare patients who spontaneously control HIV replication to levels be...
Background: HIV Controllers are rare patients who spontaneously control HIV replication to levels be...
Virtually all HIV-infected patients progress to AIDS if not treated. A group of patients, called Eli...
Virtually all HIV-infected patients progress to AIDS if not treated. A group of patients, called Eli...
The rare patients who spontaneously control HIV replication in the absence of therapy show signs of ...
Cytotoxic T lymphocytes (CTLs) play a vital part in controlling viral replication during human viral...
The rare patients who spontaneously control HIV replication in the absence of therapy show signs of ...
Cytotoxic T-lymphocytes are important for the control of viral replication during HIV infection, how...
HIV-1-specific CD8+ T cells are present in most HIV-1-infected people and play an important role in ...
HIV-specific cytotoxic T lymphocytes (CTL) are important in controlling HIV replication, but the mag...
Cytotoxic T lymphocyte (CTL) responses targeting specific HIV proteins, in particular Gag, have been...
The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effec...
The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effec...
Mapping the precise determinants of T-cell efficacy against viruses in humans is a public health pri...
HIV remains a global pandemic. No vaccine or cure exists. Most infected individuals progress to AIDS...
Background: HIV Controllers are rare patients who spontaneously control HIV replication to levels be...
Background: HIV Controllers are rare patients who spontaneously control HIV replication to levels be...
Virtually all HIV-infected patients progress to AIDS if not treated. A group of patients, called Eli...
Virtually all HIV-infected patients progress to AIDS if not treated. A group of patients, called Eli...
The rare patients who spontaneously control HIV replication in the absence of therapy show signs of ...
Cytotoxic T lymphocytes (CTLs) play a vital part in controlling viral replication during human viral...
The rare patients who spontaneously control HIV replication in the absence of therapy show signs of ...
Cytotoxic T-lymphocytes are important for the control of viral replication during HIV infection, how...
HIV-1-specific CD8+ T cells are present in most HIV-1-infected people and play an important role in ...
HIV-specific cytotoxic T lymphocytes (CTL) are important in controlling HIV replication, but the mag...
Cytotoxic T lymphocyte (CTL) responses targeting specific HIV proteins, in particular Gag, have been...
The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effec...
The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effec...
Mapping the precise determinants of T-cell efficacy against viruses in humans is a public health pri...